Peptide Compass · Research

CJC-1295: research, prices and suppliers

A synthetic analog of growth hormone-releasing hormone, studied in two variants with different durations of action.

Sources and dates are stated with individual entries. This new presentation is not a complete re-investigation of all data.

CJC-1295 is a stabilized analog of the body's own GHRH, studied in the context of the growth hormone axis. It exists in two variants: without DAC (Drug Affinity Complex), which has a short duration of action, and with DAC, which achieves a substantially extended duration through binding to serum albumin. Available human data come mainly from early clinical research in healthy adults.

Evidence

  • Two randomized, placebo-controlled trials in healthy adults with step-wise increasing amounts: a single injection of CJC-1295 with DAC raised growth hormone levels for several days and IGF-1 levels for 9 to 11 days. Teichman et al. 2006, Journal of Clinical Endocrinology & Metabolism, PMID 16352683
  • A follow-up analysis of the same subjects found that pulsatile growth hormone release was preserved even under the extended stimulation from CJC-1295 with DAC. Ionescu & Frohman 2006, Journal of Clinical Endocrinology & Metabolism, PMID 17018654

Frequently asked questions

What is the difference between CJC-1295 with and without DAC


Without DAC, the peptide is broken down within minutes, producing a short, pronounced hormone pulse. With DAC, a chemical anchor binds to albumin in the blood, extending the duration to several days, while studies indicate the pulsatile release pattern is preserved.

Is CJC-1295 an approved medication


No. CJC-1295 is not approved as a medication in the EU or the US and is sold exclusively as a research chemical for laboratory use.

What is CJC-1295 studied for in research


CJC-1295 is studied in the context of the growth hormone axis, particularly regarding the body's own release of growth hormone and the resulting IGF-1 production in the liver.

Documented prices

Prices are recorded snapshots. Each entry states its date, currency and pack variant. Shipping, tax treatment, discount conditions and availability must be rechecked in the shop. A low price is not evidence of quality.

List prices excluding shipping and discounts. Currency and product variants must be compared separately. Availability and delivered batch have not been verified.

VendorPackList pricePrice/mgRecordedSource
Driada2 mg30 EUR15.0 EUR/mg2026-09-15Product page · Ad
Peak Peptide5 mg29.9 EUR5.98 EUR/mg2026-09-15Product page · Ad
Peptide Labz5 mg35 EUR7.0 EUR/mg2026-09-15Product page · Ad
Smart Peptides5 mg39.9 EUR7.98 EUR/mg2026-09-15Product page · Ad
Europa-Peptide5 mg49.9 EUR9.98 EUR/mg2026-09-15Product page · Ad
Particle Peptides5 mg49.99 EUR10.0 EUR/mg2026-09-15Product page · Ad
Europa-Peptide5 mg64.9 EUR12.98 EUR/mg2026-09-15Product page · Ad
Particle Peptides5 mg67.99 EUR13.6 EUR/mg2026-09-15Product page · Ad
Bio BoostX10 mg49.95 EUR5.0 EUR/mg2026-09-15Product page · Ad
Peptide Shop Deutschland10 mg89 EUR8.9 EUR/mgnot establishedProduct page · Ad
DN Lab Research10 mg121 EUR12.1 EUR/mg2026-09-15Product page · Ad
Hydro Research Peptides5 mg29.99 USD6.0 USD/mg2026-09-15Source
Chameleon Peptides5 mg34.99 USD7.0 USD/mg2026-09-15Product page · Ad
Licensed Peptides5 mg38.99 USD7.8 USD/mg2026-09-15Product page · Ad
BioCollex5 mg55 USD11.0 USD/mg2026-09-15Product page · Ad
Protide Health10 mg75 USD7.5 USD/mg2026-09-15Product page · Ad
American Peptides10 mg110 USD11.0 USD/mg2026-09-15Product page · Ad

Questions about interpretation

What does the search “CJC-1295 protocol” mean?

“Protocol” is often used to mean a regimen. This page explains research and documented listings. It contains no doses, cycles or instructions for human use. An online regimen is not scientifically validated simply because it is widely shared.

Sources and data basis

These references come from the existing dataset. A link alone verifies neither a study claim nor supplier quality. Uncertainty remains explicit where records are undated or incomplete.

Where to go next

Created with AI assistance. This new edition has not yet received independent editorial review.